The landscape of pharmaceutical manufacturing and quality control is seeing a key change with crucial updates to the United States Pharmacopeia (USP) standards for container closure systems. As the deadline on December 1st, 2025, draws near, the industry must prepare to adapt to the new container closure requirements set forth by the USP. This article will give a comprehensive overview of the evolving container closure requirements for parenteral products and insightful exploration of the alterations introduced by USP <661.1>, <661.2>, and, <382> equipping pharmaceutical manufacturers with the essential knowledge to navigate the evolving regulatory compliance standards effectively. Download now to learn more.

Download Document

Please fill out the information below. If you are already registered, login and this information will be filled out for you.

Name
Company/Institution *
Please enter the name of the company or institution you work at.
Address
Street Address *
Street Address Line 2
City *
State *
Postal Code *
Country *
Please enter your mailing address.
E-mail Address *
Please enter the e-mail address you would like to be contacted at.
Work Phone Number *
Please enter the phone number you would like to be contacted at.
May an account manager contact you? *
Yes
No
By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.

Container Closure Requirements: Preparing for Updates to USP <382>, <661.1>, and <661.2>

Oops! It looks like there were some errors.

Download Document

Subscriptions

Connect with Us

Subscribe to eNewsletters